Number of American Troops Wounded Rises to Over One Hundred Fifty

What Happened?

According to the Pentagon, the number of American troops wounded by enemy fire in the war with Iran has risen to over one hundred and fifty.

Eight of the wounded were classified as serious, and one hundred and eight were designated as minor by the U.S. military. Pentagon spokesman Scott Parnell said most of those with minor injuries had already returned to duty.

The Chairman of the Joint Chiefs of Staff, General Dan Caine, issued a statement on Iran saying, ‘I think ​they're fighting, and I respect that, but ​I don't think they are more formidable than what we thought.’

Why it Matters

The increase in the number of wounded had not been previously reported, but in a war zone where conditions are challenging and chaotic, it can take time for all units involved in combat operations to report their casualties.

Personnel accountability is a core responsibility of military commanders, but with so many installations under attack over such a wide area, putting together accurate information on casualties can be more difficult due to ongoing enemy attacks. 

Where AI Meets M&A. Share Price Changes 3/12.

With AI deal flow surpassing $55B in 2025, consolidation is the direction of the market. RAD Intel is scaling inside that shift, and the entry remains early.

In 2021, RAD acquired its core AI engine. Since then, valuation has scaled from $10M to $220M+ (22x), supported by recurring 7-figure Fortune 1000 contracts.

Through its Artificial Intelligence Buyout strategy (AIBO), RAD deploys that same platform across operating businesses to compound value while isolating risk. Leadership has $9B+ in M&A experience.

RAD’s momentum is real and driving a shape price change on March 12th.

Backed by multiple Fidelity funds, selected by the Adobe Design Fund, and more than 15K investors, including insiders from Google, Meta, Youtube, and Amazon. The early window won’t stay open for long.^

Nasdaq ticker reserved: $RADI.

*Featured by Wall Street Journal, Fast Company, Bloomberg, Venture Beat, Forbes, Tech Crunch, Charles Schwab, Cheddar TV, CNBC, NYSE and NASDAQ.

Final days at $0.85/share. Price changes March 12.

An increase in casualties demonstrates that Iran can inflict harm on the U.S. military despite missile defense technologies. Even state-of-the-art defensive systems are imperfect, and given the high number of Iranian missiles and drones being launched at American military bases, it was inevitable that some would get through the defensive.

American and allied missile defense systems have performed well, hitting or disabling most of the incoming Iranian projectiles. Otherwise, the casualties would have been many times higher.

For the U.S. military, the relatively low number of casualties is unlikely to curtail combat operations against Iran. But the casualties will undoubtedly be a political issue in the 2026 mid-term elections.

Opponents of the war will use casualty figures to highlight the dangers of the war with Iran and to criticize the Trump Administration. American public support for the war in Iran remains low, and rising casualties could cause that support to sink even further.

During combat operations in Iraq and Afghanistan, service members who suffered duty-related injuries were divided into two types. Those with serious wounds were sent to permanent medical facilities in Europe or the United States to receive treatment.

Those who suffered minor injuries typically remained at their duty stations but were placed on light duty until they made a full recovery. The same type of approach appears to still be in use today when it comes to how the U.S. military handles casualties. 

How it Affects You

If combat between Iran and the United States continues, the number of American casualties will almost certainly increase. The U.S. military could still function even if the casualties reached into the thousands, but the Trump Administration would likely pay a steep political price if that happened. 

^Disclaimer: This is a paid advertisement for RAD Intel made pursuant to Regulation A+ offering and involves risk, including the possible loss of principal. The valuation is set by the Company and there is currently no public market for the Company's Common Stock. Nasdaq ticker “$RADI” has been reserved by RAD Intel and any potential listing is subject to future regulatory approval and market conditions. Brand references reflect factual platform use, not endorsement. Investor references reflect factual individual or institutional participation and do not imply endorsement or sponsorship by the referenced companies. Some media placements are earned organically, while others may be paid sponsorships or promotional placements. Please read the offering circular and related risks at invest.$RADIntel.ai.